R. J. Mohammed
Research Subjects
R. J. Mohammed has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ghufran Salman Jawad
National Diabetes Center, Mustansiriyah University
1 shared publication - Haidar Fadhil Al-Rubaye
National Diabetes Center, Mustansiriyah University
1 shared publication - Karam Gharab
National Diabetes Center, Mustansiriyah University
1 shared publication - Lujain Ali Ghannawi
National Diabetes Center, Mustansiriyah University
1 shared publication - Mohammed Amer Thamer
National Diabetes Center, Mustansiriyah University
1 shared publication Р. Д. Мухаммед
Аль-Кархский университет наук
1 shared publication
Latest Publications
- Open Access
- 3 December 2025
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 28 (5) , 442-450
Prolactin, Estrogen, HbA1c and Interleukin-12 in Iraqi Smokers Single Females
BACKGROUND : Smoking disrupts the endocrine system, altering levels of key hormones such as estrogen (E2) and prolactin (PRL). This makes the relationship between smoking and sex hormones an important research topic. IL-12 is a crucial cytokine that enhances immune responses, particularly in promoting T-cell differentiation. AIM: This study aims to assess the impact of smoking on immune function by analyzing the reduction of pro-inflammatory cytokines (e.g., IL-12) and determining whether hormonal differences exacerbate this effect in females. MATERIALS AND METHODS : Ninety serum samples were collected from healthy single females, age range (20–29) years old. The samples were divided into three groups: smokers (n=30), secondhand smokers (individuals exposed to tobacco smoke in their environment) (n=30), and non-smokers (control group, n=30). The female smokers were subdivided into 2 sub-groups: the first is based on the rate of smoking per day into heavy and light smokers, and the second group is the duration of smoking years (RESULTS : The findings revealed notable variations in the levels of IL-12, PRL, and HbA1c across all the studied groups (p-value CONCLUSION : Our findings suggest that heavy smoking adversely affects both metabolic health (increases HbA1c level) and hormonal balance in women. Also, smoking does decrease IL-12 levels, which can impair immune responses and affect overall health. While the durations of smoking (short-term vs. long-term) did not lead to notable changes in the outcomes being measured.
- 3 December 2025
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 28 (5) , 442-450
Open AccessProlactin, Estrogen, HbA1c and Interleukin-12 in Iraqi Smokers Single Females
BACKGROUND : Smoking disrupts the endocrine system, altering levels of key hormones such as estrogen (E2) and prolactin (PRL). This makes the relationship between smoking and sex hormones an important research topic. IL-12 is a crucial cytokine that enhances immune responses, particularly in promoting T-cell differentiation. AIM: This study aims to assess the impact of smoking on immune function by analyzing the reduction of pro-inflammatory cytokines (e.g., IL-12) and determining whether hormonal differences exacerbate this effect in females. MATERIALS AND METHODS : Ninety serum samples were collected from healthy single females, age range (20–29) years old. The samples were divided into three groups: smokers (n=30), secondhand smokers (individuals exposed to tobacco smoke in their environment) (n=30), and non-smokers (control group, n=30). The female smokers were subdivided into 2 sub-groups: the first is based on the rate of smoking per day into heavy and light smokers, and the second group is the duration of smoking years (RESULTS : The findings revealed notable variations in the levels of IL-12, PRL, and HbA1c across all the studied groups (p-value CONCLUSION : Our findings suggest that heavy smoking adversely affects both metabolic health (increases HbA1c level) and hormonal balance in women. Also, smoking does decrease IL-12 levels, which can impair immune responses and affect overall health. While the durations of smoking (short-term vs. long-term) did not lead to notable changes in the outcomes being measured.